Discontinuation report BREZTRI AEROSPHERE
| Report ID | 257261 |
| Drug Identification Number | 02518058 |
| Brand name | BREZTRI AEROSPHERE |
| Common or Proper name | Nom commun ou nom propre |
| Company Name | ASTRAZENECA CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | FORMOTEROL FUMARATE DIHYDRATE GLYCOPYRRONIUM BUDESONIDE |
| Strength(s) | 5MCG 7.2MCG 160MCG |
| Dosage form(s) | AEROSOL, METERED DOSE |
| Route of administration | INHALATION |
| Packaging size | Taille de l’emballage |
| ATC code | R03AL |
| ATC description | |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2025-02-16 |
| Remaining supply date | |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: [email protected]. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2025-10-11 | French | Compare |
| v3 | 2025-10-11 | English | Compare |
| v2 | 2025-10-10 | English | Compare |
| v1 | 2025-09-02 | English | Compare |
Showing 1 to 4 of 4